192 related articles for article (PubMed ID: 9476110)
1. Complement factors and their receptors.
Ember JA; Hugli TE
Immunopharmacology; 1997 Dec; 38(1-2):3-15. PubMed ID: 9476110
[TBL] [Abstract][Full Text] [Related]
2. Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans.
Pasupuleti M; Walse B; Nordahl EA; Mörgelin M; Malmsten M; Schmidtchen A
J Biol Chem; 2007 Jan; 282(4):2520-8. PubMed ID: 17132627
[TBL] [Abstract][Full Text] [Related]
3. Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement.
Sunyer JO; Boshra H; Li J
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):77-89. PubMed ID: 16112742
[TBL] [Abstract][Full Text] [Related]
4. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
5. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
6. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
7. Anaphylatoxins: their role in bacterial infection and inflammation.
Haas PJ; van Strijp J
Immunol Res; 2007; 37(3):161-75. PubMed ID: 17873401
[TBL] [Abstract][Full Text] [Related]
8. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
9. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
10. New concepts on the therapeutic control of complement anaphylatoxin receptors.
Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of the anaphylatoxins.
Hugli TE
Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
[TBL] [Abstract][Full Text] [Related]
12. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
Hugli TE
Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
[No Abstract] [Full Text] [Related]
13. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
Greer J
Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
[TBL] [Abstract][Full Text] [Related]
14. Role of the complement system in pulmonary disorders.
Regal JF
Immunopharmacology; 1997 Dec; 38(1-2):17-25. PubMed ID: 9476111
[TBL] [Abstract][Full Text] [Related]
15. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
16. The role of the complement anaphylatoxins in the recruitment of eosinophils.
DiScipio RG; Schraufstatter IU
Int Immunopharmacol; 2007 Dec; 7(14):1909-23. PubMed ID: 18039528
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the coagulation and complement system.
Amara U; Rittirsch D; Flierl M; Bruckner U; Klos A; Gebhard F; Lambris JD; Huber-Lang M
Adv Exp Med Biol; 2008; 632():71-9. PubMed ID: 19025115
[TBL] [Abstract][Full Text] [Related]
18. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
19. Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.
Surace L; Lysenko V; Fontana AO; Cecconi V; Janssen H; Bicvic A; Okoniewski M; Pruschy M; Dummer R; Neefjes J; Knuth A; Gupta A; van den Broek M
Immunity; 2015 Apr; 42(4):767-77. PubMed ID: 25888260
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the receptor for C4a is distinct from the C3a receptor.
Ames RS; Tornetta MA; Foley JJ; Hugli TE; Sarau HM
Immunopharmacology; 1997 Dec; 38(1-2):87-92. PubMed ID: 9476119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
